PTKFY:OTCMKTS
PT Kalbe Farma Unsponsored Indonesia ADR
8,50 US$
0,00%
(0,00) 1D
12 ოქტ, 10:22:09 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PTKFY...
Mkt. cap
31,60 ტრლ.
Avg. vol.
1,94 ათ.
Volume
1,43 ათ.
52-wk high
16,36 US$
52-wk low
7,63 US$
Beta
0,09
Shares outstanding
234,07 მლნ.
No. of employees
13 ათ.
Mkt. cap
31,60 ტრლ.
Avg. vol.
1,94 ათ.
Volume
1,43 ათ.
52-wk high
16,36 US$
52-wk low
7,63 US$
Beta
0,09
Shares outstanding
234,07 მლნ.
No. of employees
13 ათ.
News stories
From web sources and news partners
ad-hoc-news.de
·
1 დღის წინ
Buyback plans and results shaped Kalbe Farma stock review
Profile
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, with a distribution arm that reaches over one million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient.
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Diabetasol, Prenagen, Extra Joss and Fitbar.
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. The name "Kalbe" is a syllabic abbreviation of its founder's name: Khouw Lip Boen. Wikipedia
About PT Kalbe Farma Unsponsored Indonesia ADR
CEO-
Employees12,8 ათ.
Founded10 სექ. 1966
Headquarters-
SectorPharmaceutical industry
Websitekalbe.co.id